Identification and Analysis of Immunomodulatory Molecules in Patients With Hematologic Disorders and Healthy Volunteers

Completed

Conditions studied: Hematologic Diseases, Healthy Volunteers

In brief

This research study goal is to analyze the plasma and the cells that make up part of the immune system. We want to learn how the plasma and cells work. These may influence why one person will develop an infection and another will not, or why one person develops severe symptoms of a disease while others remain without symptoms.

Key facts

Study ID

NCT00223483

Run by

The University of Texas Health Science Center at San Antonio

People needed

512

Starts

2005-03-01

Expected to finish

2021-07-14

Last updated by the study team

2021-07-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Must be able to give blood
• Must be able to give informed consent
• Signed, written informed consent

You may not qualify if…

• Individuals with a history severe anemia, inadequate venous access, severe blood or coagulation disorders.
• Pregnant women are excluded because it is a unique immunotolerant state and will alter the profile of immunomodulatory molecules.

Where it is running

• Department of Veterans Affairs, South Texas Veterans Health Care System, Audie L. Murphy Memorial Veterans Hospital Division — San Antonio, Texas, United States
• The University of Texas Health Science Center at San Antonio — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.